JSE stronger as Covid-19 vaccine hopes lift sentiment
The all share and top 40 were up by 1.13% and 1.15%, respectively
15 July 2020 - 12:12
The JSE was firmer on Wednesday in line with European markets as progress in finding a Covid-19 vaccine lifted investor sentiment.
An experimental Covid-19 vaccine trial by US-based biotech company Moderna, which is in its early stages, showed immune response in all 45 patients, according to US researchers. ..
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.